Diovan Tablet 40mg

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Buy It Now

Active ingredient:

Valsartan

Available from:

NOVARTIS (SINGAPORE) PTE LTD

ATC code:

C09CA03

Dosage:

40.00 mg

Pharmaceutical form:

TABLET, FILM COATED

Composition:

Valsartan 40.00 mg

Administration route:

ORAL

Prescription type:

Prescription Only

Manufactured by:

Novartis Pharma Stein AG

Authorization status:

ACTIVE

Authorization date:

2005-05-20

Patient Information leaflet

                                 
 
 
 
 
DIOVAN

 
Angiotensin II antagonist 
DESCRIPTION AND 
COMPOSITION 
PHARMACEUTICAL FORMS 
Film-coated tablet. 
Diovan  40 mg:  Yellow,  ovaloid  with  bevelled  edges,  scored  on  one  side;  with  debossing 
“DO” on the scored side and “NVR” on the other side 
Diovan  80 mg:  Pale  red,  round  with  bevelled  edges,  scored  on  one  side;  with  debossing 
“D/V” on the scored side and “NVR” on the other side  
Diovan 160 mg: Grey-orange, ovaloid, scored on one side; with debossing “DX/DX” on the 
scored side and “NVR” on the other side 
Diovan 320 mg: Dark grey-violet, ovaloid with bevelled edges with debossing “DXL” on one 
side and “NVR” on the other side. 
Appearance  of  tablets  may  differ  between  countries.  Certain  dosage  strengths  may  not  be 
available in all countries. 
ACTIVE SUBSTANCE 
Active  substance:  (_S_)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-valine  (INN 
= valsartan). 
One tablet contains 40 mg, 80 mg, 160 mg or 320 mg valsartan. 
EXCIPIENTS 
Microcrystalline  cellulose,  crospovidone,  colloidal  anhydrous  silica,  magnesium  stearate, 
hypromellose,  titanium  dioxide  (E171),  Macrogol  8000,  red  iron  oxide  (E172),  yellow  iron 
oxide (E172), black iron oxide (E172; 40 mg, 160 mg and 320 mg tablets only), brown iron 
oxide (mixture of red iron oxide and black iron oxide
(320 mg tablets only). 
Pharmaceutical formulations may vary between countries. 
 
INDICATIONS 
HYPERTENSION 
Treatment of hypertension. 
Novartis 
 
Page 2 
Country Specific Package Leaflet 
 31 Oct 2013 
Diovan film-coated tablets 
 
HEART FAILURE 
Treatment of heart failure (NYHA class II-IV) in patients receiving standard therapy such as 
diuretics,  digitalis  and  either  angio
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                TRADE NAME
Diovan® 40 mg, 80 mg and 160 mg film coated tablets
DESCRIPTION AND COMPOSITION
ACTIVE SUBSTANCE
One tablet contains 40 mg, 80 mg or 160 mg of valsartan
.
PHARMACEUTICAL FORMS
Film-coated tablet (FCT)
Diovan 40 mg: Yellow, ovaloid with bevelled edges, scored on one side;
with debossing
“DO” on the scored side and “NVR” on the other side. The score
line on one side of Diovan
40mg FCT is to divide the tablet into equal doses.
Diovan 80 mg: Pale red, round with bevelled edges, scored on one side;
with debossing
“D/V” on the scored side and “NVR” on the other side
Diovan 160 mg: Grey-orange, ovaloid, scored on one side; with
debossing “DX/DX” on the
scored side and “NVR” on the other side
Appearance of tablets may differ between countries. Certain dosage
strengths may not be
available in all countries.
The score line on one side of Diovan 80mg or 160mg FCT is only to
facilitate breaking for
ease of swallowing and not to divide into equal doses.
EXCIPIENTS
Microcrystalline
cellulose,
crospovidone,
colloidal
anhydrous
silica,
magnesium
stearate,
hypromellose, titanium dioxide (E171), macrogol 8000, red iron oxide
(E172), yellow iron
oxide (E172), black iron oxide (E172; 40 mg or 160 mg tablets only),
Pharmaceutical formulations may vary between countries.
INDICATIONS
HYPERTENSION
Treatment of hypertension.
HEART FAILURE
Treatment of heart failure (NYHA class II-IV) in patients receiving
standard therapy such as
diuretics,
digitalis
and
either
angiotensin-converting
enzyme
(ACE)
inhibitors
or
beta-
blockers but not both; presence of all these standard therapies is not
mandatory.
Diovan improves morbidity in these patients, primarily via reduction
in hospitalization for
heart failure. Diovan also slows the progression of heart failure,
improves NYHA functional
Novartis
Country Specific Package Leaflet
10 Sep 2018
Page
2
Diovan film-coated
tablets
class, ejection fraction and signs and symptoms of heart failure and
improves quality of life
versus placebo (see section CLINICAL PHARMACOLO
                                
                                Read the complete document
                                
                            

Search alerts related to this product